Pharmacological management of panic disorder

References

• American Academy of PediatricsUse of psychoactive medication during pregnancy and possible effects on the fetus and newbornPediatrics2000105880710742343
   PubMed Web of Science ®Google Scholar
• American College of Obstetrician and GynecologistsTreatment with selective serotonin reuptake inhibitors during pregnancyObstet Gynecol20061081601317138801
   PubMedGoogle Scholar
• AmpolliniPMarchesiCSignifrediRTemperament and personality features in patients with major depression, panic disorder and mixed conditionsJ Affect Disord199952203710357034
   PubMed Web of Science ®Google Scholar
• [APA] American Psychiatric AssociationPractice guidelines for the treatment of patients with panic disorderAm J Psychiatry1998155Suppl 5134
   Web of Science ®Google Scholar
• [APA] American Psychiatric AssociationDiagnostic and stastical manual of mental disorders2000FourthWashington, DCAmerican Psychiatric Association
   Google Scholar
• BakkerAvan BalkomAJSpinhovenPSSRIs vs. TCAs in the treatment of panic disorder: a meta-anlsysisActa Psychiatr Scand2002106163712197851
   PubMed Web of Science ®Google Scholar
• BaldwinDSAndersonIMNuttDJEvidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association of PsychopharmacologyJ Psychopharmacol2005195679616272179
   PubMed Web of Science ®Google Scholar
• BallengerJCPanic disorder in the medical settingJ Clin Psychiatry199758Suppl 213179078989
   PubMed Web of Science ®Google Scholar
• BallengerJCClinical guidelines for establishing remission in patients with depression and anxietyJ Clin Psychiatry199960Suppl 22293410634353
   PubMed Web of Science ®Google Scholar
• BallengerJCTreatment of anxiety disorders to remissionJ Clin Psychiatry200162Suppl 125911430617
   PubMed Web of Science ®Google Scholar
• BallengerJCDavidsonJRTLecrubierYConsensus statement on panic disorder from the international consensus group on depression and anxietyJ Clin Psychiatry199859Suppl 847549707162
   PubMed Web of Science ®Google Scholar
• BandelowBSojkaFBroocksAPanic disorder during pregnancy and postpartum periodEur Psychiatry20062149550016529913
   PubMed Web of Science ®Google Scholar
• BandelowBZoharJHollahderEWorld Federation of Societies of Biological Psychiatry (WFSBP)Guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and posttraumatic stress disordersWorld J Biol Psychiatry200231719912516310
   PubMedGoogle Scholar
• BarbeyJTRooseSPSSRI safety in overdoseJ Clin Psychiatry199859Suppl 154289786310
   PubMed Web of Science ®Google Scholar
• BarlowDHGormanJMShearMKCognitive-behavioural therapy, imipramine, or their combination for panic disorder: a randomized controlled trialJAMA200028325293610815116
   PubMed Web of Science ®Google Scholar
• BerardARamosEReyEFirst trimester exposure to paroxetina and risk of cardiac malformations in infants: the importance of dosageBirth Defects Res B Dev Reprod Toxicol200680182717187388
   PubMedGoogle Scholar
• BerleJOSteenVMAamoTOBreastfeeding during maternal antidepressant treatment with serotonin reuptake inhibitors: infant exposure, clinical symptoms and cytichrome p450 genotypesJ Clin Psychiatry20046512283415367050
   PubMed Web of Science ®Google Scholar
• BradwejnJAhokasASteinDJVenlafaxine extended-release capsules in panic disorder: flexible-dose, double-blind, placebo-controlled studyBr J Psychiatry2005187352916199795
   PubMed Web of Science ®Google Scholar
• BruceSJVasileRGGoismanRMAre benzodiazepines still the medication of choice for patients with panic disorder with or without agoraphobia?Am J Psychiatry20031601432812900305
   PubMed Web of Science ®Google Scholar
• [CPA] Canadian Psychiatric AssociationClinical practice guidelines Management of anxiety disordersCan J Psychiatry2006518 suppl 29S91S16933543
   PubMed Web of Science ®Google Scholar
• ChambersCDHernandez-DiazSVan MaterLJSelective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newbornN Engl J Med20063545798716467545
   PubMed Web of Science ®Google Scholar
• CowleyDSHaEHRoy-ByrnePPDeterminants of pharmacologic treatment failure in panic disorderJ Clin Psychiatry199758555619448663
   PubMed Web of Science ®Google Scholar
• DavidsonJRTThe long-term treatment of panic disorderJ Clin Psychiatry199859Suppl 817219707158
   PubMed Web of Science ®Google Scholar
• den BoerJAPharmacotherapy of panic disorder: differential efficacy from a clinical viewpointJ Clin Psychiatry199859Suppl 83069707160
   PubMed Web of Science ®Google Scholar
• DoerflerLAConnorDFVolungisAMPanic disorder in clinically referred children and adolescentsChild Psychiatry Hum Dev2006in press
   PubMed Web of Science ®Google Scholar
• DoyleAPollackMHEstablishment of remission criteria for anxiety disordersJ Clin Psychiatry2003Suppl 1540514658990
   PubMed Web of Science ®Google Scholar
• DoyleAPollackMHLong-term management of panic disorderJ Clin Psychiatry200465Suppl 524815078115
   PubMed Web of Science ®Google Scholar
• DreessenLArntzAThe impact of personality disorders on treatment outcome of anxiety disorders: best-evidence synthesisBehav Res Ther1998364835049648326
   PubMed Web of Science ®Google Scholar
• EatonWWAnthonyJCRomanoskiAOnset and recovery from panic panic disorders in the Baltimore Epidemiologic Catchment Area follow-upBr J Psychiatry199817350179926079
   PubMed Web of Science ®Google Scholar
• Eberhard-GranMEsklidAOpjordsmoenSTreating mood disorders during pregnancy: safety considerationsDrug Saf20052869570616048355
   PubMed Web of Science ®Google Scholar
• Eberhard-GranMEsklidAOpjordsmoenSUse of psychotropic medications in treating mood disorders during lactation: practical recommendationsCNS Drugs2006201879816529525
   PubMed Web of Science ®Google Scholar
• GoddardAWBrouetteTAlmaiAEarly coadministration of clonazepam with sertraline for panic disorderArch Gen Psychiatry200158681611448376
   PubMed Web of Science ®Google Scholar
• GoismanRMWarshawMGPetersonLGPanic, agoraphobia, and panic disorder with agoraphobia. Data from a multicenter anxiety disorders studyJ Nerv Ment Dis19941827298308535
   PubMed Web of Science ®Google Scholar
• GoodwinRDGotlibIHPanic attacks and psychopathology among youthActa Psychiatr Scand20041092162114984394
   PubMed Web of Science ®Google Scholar
• GoodwinRDRoy-ByrnePPanic and suicidal ideation and suicide attempts: results from the National Comorbidity SurveyDepress Anxiety2006231243216502406
   PubMed Web of Science ®Google Scholar
• GrantBFHasinDSStinsonFSCo-occurrence of 12-month mood and anxiety disorders and personality disorders in the US: results from the national epidemiologic survey on alcohol and related conditionsJ Psychiatr Res2005391915504418
   PubMed Web of Science ®Google Scholar
• GreenblattDJvon MoltkeLLHarmatzJSDrug interactions with newer antidepressant: role of human cytochromes P450J Clin Psychiatry199859Suppl 1519279786307
   PubMed Web of Science ®Google Scholar
• HeldtEManfroGGKipperLTreating medication-resistant panic disorder: predictors of cognitive-behaviour therapy in a Brazilian public hospitalPsychother Psychosom20037243812466637
   PubMed Web of Science ®Google Scholar
• HeldtEManfroGGKipperLOne-year follow-up of pharmacotherapy-resistant patients with panic disorder treated with cognitive-behaviour therapy: outcome and predictors of remissionBehav Res Ther2006446576516038874
   PubMed Web of Science ®Google Scholar
• HischmannSDannonPMIancuIPindolol augmentation in patients with treatment-resistant panic disorder: A double-blind, placebo controlled trialJ Clin Psychopharmacol200020556911001241
   PubMed Web of Science ®Google Scholar
• HollifieldMThompsonPMRuizJEPotential effectiveness and safety of olanzapine in refractory panic disorderDepress Anxiety200521334015786486
   PubMed Web of Science ®Google Scholar
• IqbalMMSobhanTRyalsTEffects of commonly used benzodiazepines on the fetus, the neonate, and nursing infantPsychiatr Serv200253394911773648
   PubMed Web of Science ®Google Scholar
• KallenBOlaussonPOAntidepressant drugs during pregnancy and infant congenital heart defectReprod Toxicol200621221216406480
   PubMed Web of Science ®Google Scholar
• KaterndahlDARealiniJPWhere do panic sufferers seek care?J Fam Pract199540237437876780
   PubMed Web of Science ®Google Scholar
• KatschnigHAmeringMThe long-term course of panic disorder and its predictorsJ Clin Psychopharmacol199818Suppl 2611
   Web of Science ®Google Scholar
• KesslerRCBerglundPDemlerOLifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey ReplicationArch Gen Psychiatry20056259360215939837
   PubMed Web of Science ®Google Scholar
• KesslerRCChiuWTDemlerOPrevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey ReplicationArch Gen Psychiatry2005626172715939839
   PubMed Web of Science ®Google Scholar
• KesslerRCStangPWittchenHLifetime panic-depression comorbidity in the National Comorbidity SurveyArch Gen Psychiatry199855801089736006
   PubMed Web of Science ®Google Scholar
• KhanAKoltsRLRapaportMHMagnitude of placebo response and drug-placebo differences across psychiatric disordersPsychol Med200535743915918351
   PubMed Web of Science ®Google Scholar
• KleinDFDelineation of two drug-responsive anxiety syndromesPsychopharmacologia19641739740814194683
   PubMed Web of Science ®Google Scholar
• KroenkeKPatients presenting with somatic complaints: epidemiology, psychiatric comorbidity and managementInt J Methods Psychiatr Res200312344312830308
   PubMed Web of Science ®Google Scholar
• LecrubierYThe impact of comorbidity on the treatment of panic disorderJ Clin Psychiatry199859Suppl 811149707157
   PubMed Web of Science ®Google Scholar
• MalmHKlaukkaTNeuvonenPJRisks associated with selective serotonin reuptake inhibitors in pregnancyObstet Gynecol200510612899616319254
   PubMed Web of Science ®Google Scholar
• MarchesiCBrusamontiEGianniniAThe use of an emergency ward by patients with depressive or anxiety disorders: a one year follow-up studyInt J Psychiatr Med20013126575
   PubMed Web of Science ®Google Scholar
• MarchesiCBrusamontiEBorghiCAnxiety and depressive disorders in an emergency department ward of a general hospital: a control studyEmerg Med J200421175914988342
   PubMed Web of Science ®Google Scholar
• MarchesiCCantoniAFontòSThe effect of pharmacotherapy on personality disorders in panic disorder: a one year naturalistic studyJ Affect Disord2005891899416209891
   PubMed Web of Science ®Google Scholar
• MarchesiCCantoniAFontòSPredictors of symptom resolution in Panic Disorder after one year of pharmacological treatment: a naturalistic studyPharmacopsychiatry2006a3960516555166
   PubMed Web of Science ®Google Scholar
• MarchesiCCantoniAFontòSThe effect of temperament and character on response to Selective Serotonin Reuptake Inhibitors in Panic DisorderActa Psychiatr Scand2006b1142031016889591
   PubMed Web of Science ®Google Scholar
• MarchesiCDe PanfilisCCantoniAPersonality Disorders and response to medication treatment in Panic Disorder: a one year naturalistic studyProg Neuro-Psychopharmacol Biol Psychiatry200630124045
   PubMed Web of Science ®Google Scholar
• MaronEShlikJSerotoni function in panic disorder: important, but why?Neuropsychopharmacology20063111116132063
   PubMed Web of Science ®Google Scholar
• MasiGFavillaLMucciMPanic disorder in clinically referred children and adolescentsChild Psychiatry Hum Dev2000311395111089302
   PubMed Web of Science ®Google Scholar
• MasiGPariCMillepiediSPharmacological treatment options for panic disorder in children and adolescentsExpert Opin Pharmacother200675455416553570
   PubMed Web of Science ®Google Scholar
• MassionAODyckIRSheaMTPersonality disorders and time to remission in generalized anxiety disorder, social phobia, and panic disorderArch Gen Psychiatry2002594344011982447
   PubMed Web of Science ®Google Scholar
• MathewSJCaplanJDGormanJMManagement of treatment-refractory panic disorderPsychopharmacol Bul20013597110
   PubMedGoogle Scholar
• MavissakalianMRPerelJMDuration of imipramine therapy and relapse in panic disorder with agoraphobiaJ Clin Psychopharmacol200222294912006900
   PubMed Web of Science ®Google Scholar
• MitteKA meta-analysis of the efficacy of psycho- and pharmacotherapy in panic disorder with and without agoraphobiaJ Affect Disord200588274516005982
   PubMed Web of Science ®Google Scholar
• Moses-KolkoELBogenDPerelJNeonatal signs after late in utero exposure to serotonin reuptake inhibitors: literature review and implications for clinical applicationsJAMA200529323728315900008
   PubMed Web of Science ®Google Scholar
• MurphyTKBengstonMAY TanJSelective serotonin reuptake inhibitors in the treatment of paediatric anxiety disorders: a reviewInt Clin Psychopharmacology200015Suppl 2s47s63
   PubMed Web of Science ®Google Scholar
• [NICE] National Institute for Clinical ExcellenceAnxiety: management of anxiety (panic disorder, with or without agoraphobia, and generalised anxiety disorder) in adults in primary, secondary and community care. Clinical Guideline 22: December 2004National Collaborating Centre for Primary Care2004 Available on web site: http://www.nice.org.uk
   Google Scholar
• NeumeisterADaherRJCharneyDSAnxiety disorders: noradrenergic neurotrasmissionHandb Exp Pharmacol20051692052316594260
   PubMedGoogle Scholar
• NinanPTDunlopBWNeurobiology and etiology of panic disorderJ Clin Psychiatry200566Suppl l43715842181
   PubMed Web of Science ®Google Scholar
• NulmanIRovetJStewartDEChild development following exposure to tricyclic antidepressants or fluoxetine throughout fetal life: a prospective, controlled studyAm J Psychiatry200215918899512411224
   PubMed Web of Science ®Google Scholar
• OngurDFarabaughAIosifescuDVTridimensional personality questionnaire factors in major depressive disorder: relationship to anxiety disorder comorbidity and age of onsetPsychother Psychosom200574173815832068
   PubMed Web of Science ®Google Scholar
• OttoMWTubyKSGouldRAAn effect-size analysis of the relative efficacy and tolerability of serotonin selective reuptake inhibitors for panic disorderAm J Psychiatry200115819899211729014
   PubMed Web of Science ®Google Scholar
• OzkanMAltindagAToniAComorbid personality disorders in subject with panic disorder: Do personality disorders increase clinical severity?Compr Psychiatry20054620615714190
   PubMed Web of Science ®Google Scholar
• PollackMHThe pharmacotherapy of panic disorderJ Clin Psychiatry200566Suppl 423715842184
   PubMed Web of Science ®Google Scholar
• PollackMHAllgulanderMDBandelowBWCA Recommendations for the Long-Term Treatment of Panic DisorderCNS Spectr20038suppl 1173014767395
   PubMed Web of Science ®Google Scholar
• PollackMHSimonNMWorthingtonJJCombined paroxetine and clonazepam treatment strategies compared to paroxetine mono-therapy for panic disorderJ Psychopharmacol2003172768214513919
   PubMed Web of Science ®Google Scholar
• [RANZCP] Royal Australian and New Zealand College of Psychiatrists Clinical Practice Guidelines Team for Panic Disorder and AgoraphobiaAustralian and New Zealand clinical practice guidelines for the treatment of panic disorder and agoraphobiaAust N Z J Psychiatry2003376415614636376
   PubMed Web of Science ®Google Scholar
• RiedererPLachenmayerLLauxGClinical application of MAO-inhibitorsCurr Med Chem20041120334315279566
   PubMed Web of Science ®Google Scholar
• RooseSPMiyazakiMPharmacologic treatment of depression in patients with heart diseasePsychosom Med200567Suppl 1s54715953802
   PubMed Web of Science ®Google Scholar
• RosenbaumJFPollackMHPollockRAClinical issues in the long-term treatment of panic disorderJ Clin Psychiatry199657Suppl 104488917131
   PubMed Web of Science ®Google Scholar
• RossLEMcLeanLMAnxiety disorders during pregnancy and the postpartum period: a systematic reviewJ Clin Psychiatry20066712859816965210
   PubMed Web of Science ®Google Scholar
• SanzEJDe-las-CuevasCKiuruASelective serotonin reuptake inhibitors in pregnant women and neonatal withdrawal syndrome: a database analysisLancet2005365482715705457
   PubMed Web of Science ®Google Scholar
• SareenJCoxBJAfifiTOAnxiety disorders and risk for suicidal ideation and suicide attempts: a population- based study of adultsArch Gen Psychiatry20056212495716275812
   PubMed Web of Science ®Google Scholar
• SchweizerERickelsKBenzodiazepine dependence and withdrawal: a review of the syndrome and its clinical managementActa Psychiat Scand199898Suppl 39395101
   Web of Science ®Google Scholar
• ScottELPollackMHOttoMWClinician Response to treatment Refractory Panic Disorder: A Survey of PsychiatristsJ Nerv Dis19991877557
   PubMed Web of Science ®Google Scholar
• SepedeGDe BerardisDGambiFOlanzapine augmentation in treatment-resistant panic disorder: a 12-week, fixed dose, open-label trialJ Clin Psychopharmacol20062645916415705
   PubMed Web of Science ®Google Scholar
• SilvermanWKOllendickTHEvidence-Based Assessment of Anxiety and Its Disorders in Children and AdolescentsJ Clin Child Adolesc Psychol20053438041116026211
   PubMed Web of Science ®Google Scholar
• SimonNMFischmannDThe implications of medical and psychiatric comorbidity with panic disorderJ Clin Psychiatry2005481515842182
   PubMed Web of Science ®Google Scholar
• SimonNMHogeEAFischmannDAn open-label trial of risperidone augmentation for refractory anxiety disordersJ Clin Psychiatry200667381516649823
   PubMed Web of Science ®Google Scholar
• SlaapBRden BoerJAThe prediction of nonresponse to pharmacotherapy in panic disoder: a reviewDepress Anxiety2001141122211668664
   PubMed Web of Science ®Google Scholar
• SusmanJKleeBThe role of high-potency benzodiazepines in the treatment of panic disorderPrim Care Companion J Clin Psychiatry2005751115841187
   PubMedGoogle Scholar
• TaylorCKingRMargrafJUse of medication and in vivo exposure in volunteers for panic disorder researchAm J Psychiatry1989146142362817112
   PubMed Web of Science ®Google Scholar
• VickersKMc NallyRJPanic disorder and suicide attempt in the National Comorbidity SurveyDepress Anxiety200411358291
   Google Scholar
• WarnerCHBoboWWarnerCAntidepressant discontinuation syndromeAm Fam Physician2006744495616913164
   PubMed Web of Science ®Google Scholar
• WeissmanMMBlandRCCaninoGJThe cross-national epidemiology of panic disorderArch Gen Psychiatry19975430599107146
   PubMed Web of Science ®Google Scholar
• WeissmanAMLevyBTHartzAJPooled analysis of antidepressant level in lactating mothers, breast milk, and nursing infantsAm J Psychiatry200416110667815169695
   PubMed Web of Science ®Google Scholar
• WogeliusPNorgaardMMuff MunkEMaternal use of selective serotonin reup-take inhibitors and risk of adverse pregnancy outcomesPharmacoepidemiol Drug Saf200514S72
   Google Scholar
• YonkersKAEllisonJMSheraDMDescription of antipanic therapy in a prospective longitudinal studyJ Clin Psychopharmacol199616223328784654
   PubMed Web of Science ®Google Scholar
• ZajecaJTracyKAMitchellSDiscontinuation symptoms after treatment with serotonin reuptake inhibitors: a literature reviewJ Clin Psychiatry19975829179269249
   PubMed Web of Science ®Google Scholar
• ZamorskiMAAlbucherRCWhat to do when SSRIs fail: eight strategies for optimizing treatment of panic disorderAm Fam Physician20026614778412408422
   PubMed Web of Science ®Google Scholar
• ZimmermannPWittchenHUHoflerMPrimary anxiety disorders and the development of subsequent alcohol use disorder: a 4-year community study of adolescents and young adultsPsychol Med20033312112214580076
   PubMed Web of Science ®Google Scholar
• ZwanzgerPRupprechtRSelective GABAergic tretament for panic? Investigations in experimental panic induction and panic disorderJ Psychiatry Neurosci2005301677515944741
   PubMed Web of Science ®Google Scholar